Free Standard Shipping on ALL PremiershopMD Orders!

Obagi Nu-Derm® Sunfader®

Dark spot lightener with sunscreen
Sunfader SPF15 contains 4% hydroquinone which helps to minimize uneven skin tone and brown spots.

Prescription required. Contact your healthcare provider to purchase, or find a nearby physician who offers this product.

*Item sold separately from the Obagi Nu-Derm System
Not available in select states including MA, MT, NH, NY, and TX, due to state regulations regarding the ability of physicians to dispense prescription drug products in their offices. For an effective, cosmetic skin-brightening option, learn about the Obagi Nu-Derm Fx™ System.

Call for Price
Earn 124 Premier Points
In addition to the UVB protection Obagi Sunfader provides, it also contains topical prescription-strength 4% hydroquinone. Hydroquinone, a skin lightening agent, is one of the most effective treatments to help address hyperpigmentation. It works to lighten dark spots and to correct uneven skin tone, leaving you with a brighter complexion.
Each gram of Obagi Nu-Derm® Sunfader® contains:

Active Ingredients:
Hydroquinone USP, 4% (40 mg/g);
Octinoxate USP, 7.5%; Oxybenzone
USP, 5.5%

Inactive Ingredients:
Ascorbic acid, BHT, butylparaben, cetyl alcohol, disodium EDTA, glycerin, methylparaben, propylparaben, saponins, sodium lauryl sulfate, sodium metabisulfite, stearyl alcohol, tocopheryl acetate, water (aqua)

Reanee Grab

11 months ago

I was happy with this product.

Julie Williams

11 months ago

This makes skin looks good

Laura Mahoney

1 years ago

Great addition to my regimen.

Tia Wells

1 years ago

This was the added boost my Nuderm system needed.

Karla Mancilla

2 years ago

I don’t know what I would do without Obagi’s Sunfader. It has completely removed all the acne spots and sun pigmentation I had. People always stop me and ask how I have such beautiful porcelain skin. I show them pictures and they can’t believe that was my skin before Obagi. Thank you Obagi!!!

Lex Curiel

2 years ago

amazing 😍

Need to Know

Important Safety Information for Sunfader (contains 4% hydroquinone)

 

CONTRAINDICATIONS: People with prior history of sensitivity or allergic reaction to this product or any of its ingredients should not use it. The safety of topical hydroquinone use during pregnancy or in children (12 years and under) has not been established.

 

WARNINGS: Avoid contact with eyes, nose, mouth, or lips. In case of accidental contact, patient should rinse eyes, nose, mouth, or lips with water and contact physician.
Sunscreen use is an essential aspect of hydroquinone therapy because even minimal sunlight exposure sustains melanocytic activity.
Contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people.

 

Please see Prescribing Information for Sunfader

Important Safety Information for Sunfader (contains 4% hydroquinone)

 

CONTRAINDICATIONS: People with prior history of sensitivity or allergic reaction to this product or any of its ingredients should not use it. The safety of topical hydroquinone use during pregnancy or in children (12 years and under) has not been established.


WARNINGS: Avoid contact with eyes, nose, mouth, or lips. In case of accidental contact, patient should rinse eyes, nose, mouth, or lips with water and contact physician.
Sunscreen use is an essential aspect of hydroquinone therapy because even minimal sunlight exposure sustains melanocytic activity.
Contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people.

 

Please see Prescribing Information for Sunfader

 

PRECAUTIONS (ALSO SEE WARNINGS): Treatment should be limited to relatively small areas of the body at one time since some patients experience a transient skin reddening and a mild burning sensation, which does not preclude treatment.
Pregnancy Category C: Animal reproduction studies have not been conducted with topical hydroquinone. It is also not known whether hydroquinone can cause fetal harm when used topically on a pregnant woman or affect reproductive capacity. It is not known to what degree, if any, topical hydroquinone is absorbed systemically. Topical hydroquinone should be used on pregnant women only when clearly indicated.

 

Nursing Mothers: It is not known whether topical hydroquinone is absorbed or excreted in human milk. Caution is advised when topical hydroquinone is used by a nursing mother.

 

Pediatric Usage: Safety and effectiveness in children below the age of 12 years have not been established.

 

Use of the product should be discontinued if hypersensitivity to any of the ingredients is noted.

Important Safety Information for Sunfader (contains 4% hydroquinone)

 

CONTRAINDICATIONS: People with prior history of sensitivity or allergic reaction to this product or any of its ingredients should not use it. The safety of topical hydroquinone use during pregnancy or in children (12 years and under) has not been established.

 

WARNINGS: Avoid contact with eyes, nose, mouth, or lips. In case of accidental contact, patient should rinse eyes, nose, mouth, or lips with water and contact physician.
Sunscreen use is an essential aspect of hydroquinone therapy because even minimal sunlight exposure sustains melanocytic activity.
Contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people.

 

Please see Prescribing Information for Sunfader

How to Use

  • A thin application should be applied once or twice daily or as directed by a physician.
  • Sun exposure should be limited by using a sunscreen agent or protective clothing to cover bleached skin when using and after using this product in order to prevent darkening for reoccurring.
  • Please see above for additional important safety information
  • Store at controlled room temperature: 15°C–25°C (59°F–77°F)
  • Keep out of direct sunlight
  • A thin application should be applied once or twice daily or as directed by a physician.
  • Sun exposure should be limited by using a sunscreen agent or protective clothing to cover bleached skin when using and after using this product in order to prevent darkening for reoccurring.
  • Please see above for additional important safety information
  • Store at controlled room temperature: 15°C–25°C (59°F–77°F)
  • Keep out of direct sunlight

FAQs